Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Return on Equity (2016 - 2025)

Historic Return on Equity for Editas Medicine (EDIT) over the last 10 years, with Q3 2025 value amounting to 12.11%.

  • Editas Medicine's Return on Equity fell 110800.0% to 12.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.11%, marking a year-over-year decrease of 110800.0%. This contributed to the annual value of 0.98% for FY2024, which is 5500.0% down from last year.
  • Latest data reveals that Editas Medicine reported Return on Equity of 12.11% as of Q3 2025, which was down 110800.0% from 5.75% recorded in Q2 2025.
  • Editas Medicine's 5-year Return on Equity high stood at 0.27% for Q2 2021, and its period low was 12.11% during Q3 2025.
  • Moreover, its 5-year median value for Return on Equity was 0.52% (2024), whereas its average is 1.55%.
  • As far as peak fluctuations go, Editas Medicine's Return on Equity surged by 3200bps in 2021, and later tumbled by -110800bps in 2025.
  • Over the past 5 years, Editas Medicine's Return on Equity (Quarter) stood at 0.34% in 2021, then crashed by -68bps to 0.57% in 2022, then increased by 25bps to 0.43% in 2023, then plummeted by -258bps to 1.53% in 2024, then plummeted by -691bps to 12.11% in 2025.
  • Its Return on Equity stands at 12.11% for Q3 2025, versus 5.75% for Q2 2025 and 2.55% for Q1 2025.